Literature DB >> 22314387

Deferoxamine reverses radiation induced hypovascularity during bone regeneration and repair in the murine mandible.

Aaron S Farberg1, Xi L Jing, Laura A Monson, Alexis Donneys, Catherine N Tchanque-Fossuo, Sagar S Deshpande, Steven R Buchman.   

Abstract

BACKGROUND: Deferoxamine (DFO) is an iron-chelating agent that has also been shown to increase angiogenesis. We hypothesize that the angiogenic properties of DFO will improve bone regeneration in distraction osteogenesis (DO) after x-ray radiation therapy (XRT) by restoring the vascularity around the distraction site.
MATERIAL AND METHODS: Three groups of Sprague-Dawley rats underwent distraction of the left mandible. Two groups received pre-operative fractionated XRT, and one of these groups was treated with DFO during distraction. After consolidation, the animals were perfused and imaged with micro-CT to calculate vascular radiomorphometrics.
RESULTS: Radiation inflicted a severe diminution in the vascular metrics of the distracted regenerate and consequently led to poor clinical outcome. The DFO treated group revealed improved DO bone regeneration with a substantial restoration and proliferation of vascularity.
CONCLUSIONS: This set of experiments quantitatively demonstrates the ability of DFO to temper the anti-angiogenic effect of XRT in mandibular DO. These exciting results suggest that DFO may be a viable treatment option aimed at mitigating the damaging effects of XRT on new bone formation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314387      PMCID: PMC3322244          DOI: 10.1016/j.bone.2012.01.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  26 in total

1.  Radiation effects on osteoblasts in vitro: a potential role in osteoradionecrosis.

Authors:  T J Gal; T Munoz-Antonia; C A Muro-Cacho; D W Klotch
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-09

Review 2.  Tools and techniques for craniofacial tissue engineering.

Authors:  Stephen M Warren; Kenton D Fong; Constance M Chen; Elizabeth G Loboa; Catherine M Cowan; H Peter Lorenz; Michael T Longaker
Journal:  Tissue Eng       Date:  2003-04

Review 3.  Role of hypoxia inducible factor-1 alpha pathway in bone regeneration.

Authors:  C Wan; S R Gilbert; Y Wang; X M Cao; X Shen; G Ramaswamy; K A Jacobsen; Z S Alaql; L C Gerstenfeld; T A Einhorn; A W Eberhardt; L Deng; R E Guldberg; T L Clemens
Journal:  J Musculoskelet Neuronal Interact       Date:  2008 Oct-Dec       Impact factor: 2.041

4.  Dose-response effect of human equivalent radiation in the murine mandible: part I. A histomorphometric assessment.

Authors:  Catherine N Tchanque-Fossuo; Laura A Monson; Aaron S Farberg; Alexis Donneys; Aria J Zehtabzadeh; Elizabeth R Razdolsky; Steven R Buchman
Journal:  Plast Reconstr Surg       Date:  2011-07       Impact factor: 4.730

5.  Rat mandibular distraction osteogenesis: latency, rate, and rhythm determine the adaptive response.

Authors:  M F Paccione; B J Mehrara; S M Warren; J A Greenwald; J A Spector; J S Luchs; M T Longaker
Journal:  J Craniofac Surg       Date:  2001-03       Impact factor: 1.046

6.  Unique rodent model of distraction osteogenesis of the mandible.

Authors:  Steven R Buchman; Michael A Ignelzi; Caius Radu; Jonathan Wilensky; Andrew H Rosenthal; Lawrence Tong; Samuel T Rhee; Steven A Goldstein
Journal:  Ann Plast Surg       Date:  2002-11       Impact factor: 1.539

7.  The effects of ionizing radiation on osteoblast-like cells in vitro.

Authors:  M E Dudziak; P B Saadeh; B J Mehrara; D S Steinbrech; J A Greenwald; G K Gittes; M T Longaker
Journal:  Plast Reconstr Surg       Date:  2000-10       Impact factor: 4.730

Review 8.  Radiation-therapy effects on bone density.

Authors:  John W Hopewell
Journal:  Med Pediatr Oncol       Date:  2003-09

9.  Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review.

Authors:  T Reuther; T Schuster; U Mende; A Kübler
Journal:  Int J Oral Maxillofac Surg       Date:  2003-06       Impact factor: 2.789

10.  Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.

Authors:  Xing Shen; Chao Wan; Girish Ramaswamy; Mahendra Mavalli; Ying Wang; Craig L Duvall; Lian Fu Deng; Robert E Guldberg; Alan Eberhart; Thomas L Clemens; Shawn R Gilbert
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

View more
  27 in total

1.  Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.

Authors:  Alexis Donneys; Noah S Nelson; Joseph E Perosky; Yekaterina Polyatskaya; Jose J Rodriguez; Christian Figueredo; Cheyenne A Vasseli; Hannah C Ratliff; Sagar S Deshpande; Kenneth M Kozloff; Steven R Buchman
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

2.  Nonvascularized Bone Graft Reconstruction of the Irradiated Murine Mandible: An Analogue of Clinical Head and Neck Cancer Treatment.

Authors:  Kevin M Urlaub; Russell E Ettinger; Noah S Nelson; Jessie M Hoxie; Alicia E Snider; Joseph E Perosky; Yekaterina Polyatskaya; Alexis Donneys; Steven R Buchman
Journal:  J Craniofac Surg       Date:  2019 Mar/Apr       Impact factor: 1.046

3.  Topical Deferoxamine Alleviates Skin Injury and Normalizes Atomic Force Microscopy Patterns Following Radiation in a Murine Breast Reconstruction Model.

Authors:  Alicia E Snider; Jeremy V Lynn; Kevin M Urlaub; Alexis Donneys; Yekaterina Polyatskaya; Noah S Nelson; Russell E Ettinger; Geoffrey C Gurtner; Mark M Banaszak Holl; Steven R Buchman
Journal:  Ann Plast Surg       Date:  2018-11       Impact factor: 1.539

4.  Stem cell therapy remediates reconstruction of the craniofacial skeleton after radiation therapy.

Authors:  Sagar S Deshpande; Kathleen K Gallagher; Alexis Donneys; Catherine N Tchanque-Fossuo; Deniz Sarhaddi; Hongli Sun; Paul H Krebsbach; Steven R Buchman
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

5.  Clinical Use of Deferoxamine in Distraction Osteogenesis of Irradiated Bone.

Authors:  Arash Momeni; Scott Rapp; Alexis Donneys; Steven R Buchman; Derrick C Wan
Journal:  J Craniofac Surg       Date:  2016-06       Impact factor: 1.046

6.  Translational treatment paradigm for managing non-unions secondary to radiation injury utilizing adipose derived stem cells and angiogenic therapy.

Authors:  Alexis Donneys; Jordan T Blough; Noah S Nelson; Joseph E Perosky; Sagar S Deshpande; Stephen Y Kang; Peter A Felice; Christian Figueredo; Jonathan R Peterson; Kenneth M Kozloff; Benjamin Levi; Douglas B Chepeha; Steven R Buchman
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

7.  Targeting angiogenesis as a therapeutic means to reinforce osteocyte survival and prevent nonunions in the aftermath of radiotherapy.

Authors:  Alexis Donneys; Noah S Nelson; Erin E Page; Sagar S Deshpande; Peter A Felice; Catherine N Tchanque-Fossuo; Joshua P Spiegel; Steven R Buchman
Journal:  Head Neck       Date:  2014-07-10       Impact factor: 3.147

8.  Deferoxamine enhances the migration of dental pulp cells via hypoxia-inducible factor 1α.

Authors:  Rong Du; Junjun Zhao; Yang Wen; Yaqin Zhu; Long Jiang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

9.  Deferoxamine expedites consolidation during mandibular distraction osteogenesis.

Authors:  Alexis Donneys; Sagar S Deshpande; Catherine N Tchanque-Fossuo; Kelsey L Johnson; Jordan T Blough; Joseph E Perosky; Kenneth M Kozloff; Peter A Felice; Noah S Nelson; Aaron S Farberg; Benjamin Levi; Steven R Buchman
Journal:  Bone       Date:  2013-04-15       Impact factor: 4.398

10.  Vascular analysis as a proxy for mechanostransduction response in an isogenic, irradiated murine model of mandibular distraction osteogenesis.

Authors:  Sagar S Deshpande; Alexis Donneys; Stephen Y Kang; Erin E Page; Peter A Felice; Lauren Kiryakoza; Noah S Nelson; Jose Rodriguez; Samir S Deshpande; Steven R Buchman
Journal:  Microvasc Res       Date:  2014-08-27       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.